Randomized Trialhigh evidence

Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial.

JAMA·October 5, 2026·PMID 42832220

Why it matters

Lung cancer screening encounters are a key opportunity to address smoking, but effective cessation support for underserved populations is unclear. This trial shows that modest financial incentives can meaningfully improve quit rates, while free pharmacotherapy alone did not add benefit over brief referral.

Infographic summary of Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled